NO920648L - 4-pyrimidonderivater, deres fremstilling og anvendelse - Google Patents

4-pyrimidonderivater, deres fremstilling og anvendelse

Info

Publication number
NO920648L
NO920648L NO92920648A NO920648A NO920648L NO 920648 L NO920648 L NO 920648L NO 92920648 A NO92920648 A NO 92920648A NO 920648 A NO920648 A NO 920648A NO 920648 L NO920648 L NO 920648L
Authority
NO
Norway
Prior art keywords
alkyl
optionally
substituted
branched
nucleus
Prior art date
Application number
NO92920648A
Other languages
English (en)
Norwegian (no)
Other versions
NO920648D0 (no
Inventor
Christian Hoornaert
Marc Daumas
Michel Aletru
Jean-Claude Muller
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO920648D0 publication Critical patent/NO920648D0/no
Publication of NO920648L publication Critical patent/NO920648L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO92920648A 1991-02-20 1992-02-19 4-pyrimidonderivater, deres fremstilling og anvendelse NO920648L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9102032A FR2672892B1 (fr) 1991-02-20 1991-02-20 Derives de 4-pyrimidinones, leur preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
NO920648D0 NO920648D0 (no) 1992-02-19
NO920648L true NO920648L (no) 1992-08-21

Family

ID=9409925

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920648A NO920648L (no) 1991-02-20 1992-02-19 4-pyrimidonderivater, deres fremstilling og anvendelse

Country Status (23)

Country Link
EP (1) EP0500409B1 (de)
JP (1) JP2529798B2 (de)
KR (1) KR920016434A (de)
CN (1) CN1034171C (de)
AT (1) ATE135695T1 (de)
AU (1) AU650319B2 (de)
CA (1) CA2061456A1 (de)
CS (1) CS49092A3 (de)
DE (1) DE69209113T2 (de)
DK (1) DK0500409T3 (de)
ES (1) ES2086090T3 (de)
FI (1) FI920720A7 (de)
FR (1) FR2672892B1 (de)
GR (1) GR3019404T3 (de)
HU (2) HUT60477A (de)
IE (1) IE76145B1 (de)
IL (1) IL101014A (de)
MX (1) MX9200690A (de)
NO (1) NO920648L (de)
NZ (1) NZ241659A (de)
PL (1) PL168617B1 (de)
RU (1) RU2073675C1 (de)
ZA (1) ZA921203B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
FR2700543B1 (fr) * 1993-01-15 1995-03-17 Synthelabo Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique.
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
CN102369205B (zh) 2009-01-30 2014-10-29 武田药品工业株式会社 稠环化合物和其用途
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
SG52709A1 (en) * 1989-06-30 1998-09-28 Du Pont Substituted imidazoles
EP0407342A3 (en) * 1989-07-06 1991-07-10 Ciba-Geigy Ag Pyrimidine derivatives
EP0424317A3 (en) * 1989-10-19 1991-09-25 Ciba-Geigy Ag Pyrimidines
EP0435827A3 (en) * 1989-12-28 1991-11-13 Ciba-Geigy Ag Diaza compounds
EP0522038A4 (en) * 1990-03-30 1993-05-26 Merck & Co. Inc. Substituted pyrimidines, pyrimidinones and pyridopyrimidines
IE912114A1 (en) * 1990-07-02 1992-01-15 Union Pharma Scient Appl Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present

Also Published As

Publication number Publication date
EP0500409B1 (de) 1996-03-20
ZA921203B (en) 1992-11-25
PL168617B1 (pl) 1996-03-29
IE920525A1 (en) 1992-08-26
ATE135695T1 (de) 1996-04-15
AU650319B2 (en) 1994-06-16
DK0500409T3 (da) 1996-07-15
PL293531A1 (en) 1992-08-24
DE69209113T2 (de) 1996-10-31
GR3019404T3 (en) 1996-06-30
RU2073675C1 (ru) 1997-02-20
EP0500409A1 (de) 1992-08-26
FI920720A7 (fi) 1992-08-21
IL101014A0 (en) 1992-11-15
JP2529798B2 (ja) 1996-09-04
MX9200690A (es) 1992-08-01
CN1064269A (zh) 1992-09-09
NO920648D0 (no) 1992-02-19
JPH04346980A (ja) 1992-12-02
ES2086090T3 (es) 1996-06-16
HUT60477A (en) 1992-09-28
FI920720A0 (fi) 1992-02-19
FR2672892B1 (fr) 1994-01-14
HU9200532D0 (en) 1992-05-28
IL101014A (en) 1996-06-18
CN1034171C (zh) 1997-03-05
KR920016434A (ko) 1992-09-24
CA2061456A1 (en) 1992-08-21
CS49092A3 (en) 1992-09-16
NZ241659A (en) 1993-03-26
HU211886A9 (en) 1995-12-28
FR2672892A1 (fr) 1992-08-21
AU1105992A (en) 1992-08-27
DE69209113D1 (de) 1996-04-25
IE76145B1 (en) 1997-10-08

Similar Documents

Publication Publication Date Title
NO920648L (no) 4-pyrimidonderivater, deres fremstilling og anvendelse
NO2015020I2 (no) Ceritinib eller et farmasøytisk akseptabelt salt derav
AP1902A (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
AR047529A1 (es) Compuestos de quinolina sustituidos
NO20064166L (no) Utvalgte CGRP-antagonister, deres fremstilling og deres anvendelse som medikanmenter
NO20015447L (no) Kinolinderivater som inhibitorer av MEK enzymer
WO2003024441A1 (en) Novel use of tricyclic compound
NO20015669L (no) Heterocykliske substituerte aminoazacykler nyttige som sentralnervesystemmidler
NO20072409L (no) Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser
EP1642880A4 (de) Proteininhibitoren der hsp90-familie
EP1657242A4 (de) Imidazopyridinderivate
EA200602019A1 (ru) Производные пиперазина и их применение для борьбы с вредителями
AR042002A1 (es) Benzoxazinonas sustituidas, proceso de obtencion y usos para tratamiento de enfermedades del sistema nervioso central.
DE60011269D1 (de) Azaidole mit serotonin rezeptor affinität
NO20071754L (no) Biotinylerte heksadekasakkarider, fremstilling og anvendelse derav
IT1317048B1 (it) Uso dell'acido pamoico o di un suo derivato, o di un suo analogo, perla preparazione di un medicamento per il trattamento di patologie
EP1813270A4 (de) Proteininhibitoren der hsp90-familie
DK671688A (da) 2-(piperazinyl)-2-oxoethylensubstituerede flavonoidderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske midler indeholdende disse
BR112012029033A2 (pt) compostos
DE60012508D1 (de) Aminosäuren mit polycyclischer struktur als pharmaka
AR043920A1 (es) Derivados de oxazol, su produccion y uso como agentes farmaceuticos
BRPI0416982A (pt) derivados da indolina espirocondensados como pesticidas
DE69301639D1 (de) Tetrahydronaphtalenderivate, ihre Herstellung und ihre therapeutische Verwendung
FR2835834B1 (fr) Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments
DK0641784T3 (da) Benzimidazolderivat, fremgangsmåde til fremstilling af dette, antiemetisk middel indeholdende dette som aktiv ingrediens sa